The Pharmaceutical Journal
April 29, 2000

Back issues

Return to PJ Online Home Page

News

Clinical

The Society

Continuing education

Articles

Forum

Products

Notice-Board

Comment

An Onlooker's Notebook   640

Leading Article   641

News   642-644

Clinical Pharmacy   645-646

The Society   647-653

Broad Spectrum   654

Letters to the Editor   655-658

Continuing education   659-663

Articles   664-673

Forum   674-676

Products   677

Notice-Board   678

Front Cover Picture

Digitalis lanata is the plant source of the antiarrhythmic drug digoxin. Antiarrhythmic agents are the subject of the second article in our continuing education series on atrial fibrillation (p659).

Generics clampdown

The Government has announced plans to scrap Category D and impose statutory maximum prices for generic products (p642). The PSNC says the proposed changes must not hurt contractors (p642). Leading article (p641). Letters - Price should be agreed and Protest! (p656).

Council candidates' responses

This week we publish Council candidates' answers to three questions on topical issues put to them by The Journal (p647).

Exploiting hypoxia

An article this week reviews the causes of hypoxia in various disease states and discusses how the condition can be exploited in the development of new diagnostic agents and treatments (p666).

BPSA conference

At their conference recently, members of the British Pharmaceutical Students Association called for records to be kept for all extemporaneous dispensing (p674).